These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
402 related items for PubMed ID: 2999343
1. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity. Berkel AI, Henle W, Henle G, Ersoy F, Sanal O, Klein G, Yeğin O. Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343 [Abstract] [Full Text] [Related]
4. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia]. Okano M. Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855 [Abstract] [Full Text] [Related]
5. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G, Mellstedt H, Masucci MG, Szigeti R, Ernberg I, Björkholm M, Tsukuda K, Henle G, Henle W, Pearson G. Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984 [Abstract] [Full Text] [Related]
6. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX. Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282 [Abstract] [Full Text] [Related]
7. Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy. Shimakage M, Ikegami N, Chatani M, Yoshino K, Sato T. Biken J; 1987 Jun 15; 30(2):45-51. PubMed ID: 2830879 [Abstract] [Full Text] [Related]
8. Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. Ferrell PB, Aitcheson CT, Pearson GR, Tan EM. J Clin Invest; 1981 Mar 15; 67(3):681-7. PubMed ID: 6259207 [Abstract] [Full Text] [Related]
9. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia. Vilmer E, Lenoir GM, Virelizier JL, Griscelli C. Clin Exp Immunol; 1984 Feb 15; 55(2):249-56. PubMed ID: 6321070 [Abstract] [Full Text] [Related]
10. Epstein-Barr virus-related antibody pattern in uveitis. Sunakawa M, Okinami S. Jpn J Ophthalmol; 1985 Feb 15; 29(4):423-8. PubMed ID: 3007826 [Abstract] [Full Text] [Related]
12. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma. Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP. Oral Oncol; 2008 Aug 15; 44(8):784-92. PubMed ID: 18206420 [Abstract] [Full Text] [Related]
13. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology. Faggioni A, Corradini C, Venanzoni M, Cardi G, Bevere F, Barile G, Zompetta C, Frati L. J Exp Pathol; 1987 Aug 15; 3(4):471-7. PubMed ID: 2842480 [Abstract] [Full Text] [Related]
14. Epstein-Barr virus (EBV) antibodies in children with non-Hodgkin's lymphomas. Roubalová K, Weinreb M, Roubal J, Kodet R, Koutecký J, Vonka V. Acta Virol; 1988 Jul 15; 32(4):339-48. PubMed ID: 2903639 [Abstract] [Full Text] [Related]
15. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis. Touge C, Agawa H, Sairenji T, Inoue Y. Arch Virol; 2006 May 15; 151(5):895-903. PubMed ID: 16362642 [Abstract] [Full Text] [Related]
16. Epstein-Barr virus in pediatric patients after renal transplantation. Schwab M, Böswald M, Korn K, Ruder H. Clin Nephrol; 2000 Feb 15; 53(2):132-9. PubMed ID: 10711415 [Abstract] [Full Text] [Related]
17. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly. Ternák G, Szúcs G, Uj M. Acta Microbiol Immunol Hung; 1997 Feb 15; 44(2):133-40. PubMed ID: 9330661 [Abstract] [Full Text] [Related]
18. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients. Jumbou O, Mollat C, N'Guyen JM, Billaudel S, Litoux P, Dréno B. Br J Dermatol; 1997 Feb 15; 136(2):212-6. PubMed ID: 9068734 [Abstract] [Full Text] [Related]
19. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients. Masucci G, Mellstedt H, Henle G, Henle W, Rymo L, Masucci MG, Ernberg I, Klein G. Int J Cancer; 1989 Jun 15; 43(6):1017-21. PubMed ID: 2543639 [Abstract] [Full Text] [Related]
20. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome. Jones JF, Williams M, Schooley RT, Robinson C, Glaser R. Arch Intern Med; 1988 Sep 15; 148(9):1957-60. PubMed ID: 2843138 [Abstract] [Full Text] [Related] Page: [Next] [New Search]